Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Up 797.8% in August

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) was the recipient of a significant increase in short interest in August. As of August 31st, there was short interest totaling 34,223 shares, an increase of 797.8% from the August 15th total of 3,812 shares. Based on an average daily trading volume, of 114,861 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.0% of the shares of the stock are sold short.

Wall Street Analyst Weigh In

SGIOY has been the subject of several recent analyst reports. The Goldman Sachs Group raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Monday, June 15th. Jefferies Financial Group raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Finally, Zacks Research upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research report on Monday, May 25th. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, Shionogi & Co., Ltd. Unsponsored ADR presently has a consensus rating of “Buy”.

Shionogi & Co., Ltd. Unsponsored ADR Stock Up 0.2%

Shares of OTCMKTS SGIOY opened at $9.04 on Friday. Shionogi & Co., Ltd. Unsponsored ADR has a 12 month low of $7.65 and a 12 month high of $12.00. The company has a current ratio of 1.14, a quick ratio of 1.46 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $15.39 billion, a price-to-earnings ratio of 9.04, a PEG ratio of 3.23 and a beta of 0.08. The business has a 50-day moving average of $8.96 and a 200-day moving average of $9.60.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last announced its earnings results on Monday, August 3rd. The company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.18. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 46.67% and a return on equity of 16.13%. The business had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $970.69 million. Sell-side analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.82 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, the company has built its business around drug discovery and has a particular focus on infectious diseases, including antiviral and antibacterial treatments.

Shionogi’s products include Xofluza (baloxavir marboxil), an oral treatment for influenza, and Fetcroja (cefiderocol), an antibiotic used for certain difficult-to-treat bacterial infections.